The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer

Gynecologic Oncology

Volumn 64, Issue 1, 1997, Pages 26-34

  Shimabukuro, Koji ^a   Toyamo Sorimachi, Noriko ^b   Ozaki, Yoshikazu ^c   Goi, Takanori ^d   Furukawa, Koichi ^e   Miyasaka, Masayuki ^f   Aso, Takeshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADENOCARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STROMA CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

EID: 18244423555     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4530     Document Type: Article

References (23)

1. 1. Frost, P., and Levin, B. Clinical implications of metastatic process, Lancet 339, 1459-1461 (1992).
2. 2. Azanovoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., and Liotta, L. A. Molecular aspects of tumor invasion and metastasis, Cancer 71, 1368-1383 (1993).
3. 3. Takeichi, M. Cadherins in cancer cell: Implications for invasion and metastasis, Curr. Opin. Cell Biol. 5, 806-811 (1993).
4. 4. Uchida, A., and Fukata, H. Role of NK cell cytotoxic factor against fresh human tumors, Nat. Immun. 12(4-5), 267-278 (1993).
5. 5. Takada, A., Ohomori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M., and Kannagi, R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium, Cancer Res. 53, 354-361 (1993).
6. 6. Lesley, J. CD44 and its interaction with extracellular matrix, Adv. Immunol. 54, 271-335 (1993).
7. 7. Screton, G. R., Bell, M. V., Jackson, D. G., Cornells, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatatively spliced exons, Proc. Natl. Acad. Sci. USA 89, 12160-12164 (1992).
8. 8. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haußmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell 65, 13-24 (1991).
9. 9. Matsumura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation, Lancet 340, 1053-1058 (1992).
10. 10. Harn, H. J., Ho, L. I., Chang, J. I., Wu, C. W., Jiang, S. Y., Lee, H. S., and Lee, W. H. Differential expression of the human metastasis adhesion molecule CD44v in normal and carcinomatous stomach mucosa of Chinese subjects, Cancer 75, 1065-1071 (1995).
11. 11. Dall, P., Heider, K. H., Sinn, H. P., Skroch-Angel, P., Adolf, G., Kaufmann, M., Herrlich, P., and Ponta, H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer, Int. J. Cancer 60, 471-477 (1995).
12. 12. Joensuu, H., Klemi, P. J., Toikannen, S., and Jalkanen, S. Glycoprotein CD44 expression and its association with survival in breast cancer, Am. J. Pathol. 143, 867-874 (1993).
13. 13. Kuppner, M. C., Van Meir, E., Gauthier, Th., Hamou, M. F., and DeTribolet, N. Differential expression of the CD44 molecule in human brain tumors, Int. J. Cancer 50, 572-577 (1992).
14. 14. Cannistra, S. A., DeFranzo, B., Niloff, J., and Ottensmeier, C. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines, Clin. Cancer Res. 1, 333-342 (1995).
15. 15. Cannistra, S. A., Abu-Jawdeh, G., Niloff, J., Strobel, T., Swanson, L., Andersen, J., and Ottensmeier, C. CD44 variant expression is a common feature of epithelial ovarian cancer: Lack of association with standard prognostic factors, J. Clin. Oncol. 13, 1912-1921 (1995).
16. 16. Fujita, N., Yaegashi, N., Ide, Y., Sato, S., Nakamura, M., Ishiwata, I., and Yajima, A. Expression of CD44 in normal human versus tumor endometrial tissues: Possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells, Cancer Res. 54, 3922-3928 (1994).
17. 17. Dall, P., Heider, K. H., Hekele, A., Minckwitz, G., Kaufmann, M., Ponta, H., and Herrlich, P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium, Cancer Res. 54, 3337-3341 (1994).
18. 18. Arcari, P., Martinelli, R., and Salvatore, F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species, Nucleic Acids Res. 12, 9179-9189 (1984).
19. 19. Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., and Zöller, M. Prevention of tumor metastasis formation by anti-variant CD44, J. Exp. Med. 177, 443-455 (1993).
20. 20. Hofmann, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P., and Günthert, U. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines, Cancer Res. 51, 5292-5297 (1991).
21. 21. Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., and Funke, I. E-cadherin expression in primary and metastatic gastric cancer: Down regulation correlates with cellular dedifferentiation and glandular disintegration, Cancer Res. 53, 1690-1695 (1993).
22. 22. Pignattelli, M., Ansari, T. W., Gunter, P., Liu, D., Hirano, S., Takeichi, M., Kloppel, G., and Lemoine, N. R. Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage, J. Pathol. 174(4), 243-248 (1994).
23. 23. Imachi, M., Tsukamoto, M., Matsuyama, T., and Nakano, H. Pulmonary metastasis from carcinoma of the uterine cervix, Gynecol. Oncol. 33, 189-192 (1989).